Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 291 entries
Sorted by: Best Match Show Resources per page
Internship programme in medical education--an overview.

NIHAE bulletin

Trakroo PL, Murali I, Gandhi HS.
PMID: 1024177
NIHAE Bull. 1976;9(1):49-56.

No abstract available.

Cite
Trakroo PL, Murali I, Gandhi HS. Internship programme in medical education--an overview. NIHAE Bull. 1976;9(1):49-56
Trakroo, P. L., Murali, I., & Gandhi, H. S. (1976). Internship programme in medical education--an overview. NIHAE bulletin, 9(1), 49-56.
Trakroo, P L, et al. "Internship programme in medical education--an overview." NIHAE bulletin vol. 9,1 (1976): 49-56.
Trakroo PL, Murali I, Gandhi HS. Internship programme in medical education--an overview. NIHAE Bull. 1976;9(1):49-56. PMID: 1024177.
Copy Download .nbib Format: NLM
Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms.

Pharmacology research & perspectives

Suzuki H, Sasaki E, Nakagawa A, Muraki Y, Hatano N, Muraki K.
PMID: 27433342
Pharmacol Res Perspect. 2016 Apr 07;4(3):e00232. doi: 10.1002/prp2.232. eCollection 2016 Jun.

The effects of diclofenac (Dic), an acetic acid derivative-type nonsteroidal anti-inflammatory drug, were examined on the function of transient receptor potential (TRP) melastatin (TRPM) 3 (TRPM3) in human embryonic kidney 293 cell-line (HEK293) cells with recombinant human TRPM3 isoforms...

Cite
Suzuki H, Sasaki E, Nakagawa A, et al. Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms. Pharmacol Res Perspect. 2016;4(3):e00232doi: 10.1002/prp2.232.
Suzuki, H., Sasaki, E., Nakagawa, A., Muraki, Y., Hatano, N., & Muraki, K. (2016). Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms. Pharmacology research & perspectives, 4(3), e00232. https://doi.org/10.1002/prp2.232
Suzuki, Hiroka, et al. "Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms." Pharmacology research & perspectives vol. 4,3 (2016): e00232. doi: https://doi.org/10.1002/prp2.232
Suzuki H, Sasaki E, Nakagawa A, Muraki Y, Hatano N, Muraki K. Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms. Pharmacol Res Perspect. 2016 Apr 07;4(3):e00232. doi: 10.1002/prp2.232. eCollection 2016 Jun. PMID: 27433342; PMCID: PMC4876142.
Copy Download .nbib Format: NLM
The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing.

Biochemistry and biophysics reports

Shimotai Y, Goto T, Matsuzaki Y, Muraki Y, Sugawara K, Hongo S.
PMID: 29124162
Biochem Biophys Rep. 2015 Jul 08;3:1-6. doi: 10.1016/j.bbrep.2015.07.001. eCollection 2015 Sep.

CM2 is an integral membrane protein encoded by the influenza C virus M gene. To examine the effects of the cytoplasmic tail of CM2 on its biochemical properties, deletion and substitution mutations were introduced into CM2 cytoplasmic tail at...

Cite
Shimotai Y, Goto T, Matsuzaki Y, et al. The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing. Biochem Biophys Rep. 2015;3:1-6doi: 10.1016/j.bbrep.2015.07.001.
Shimotai, Y., Goto, T., Matsuzaki, Y., Muraki, Y., Sugawara, K., & Hongo, S. (2015). The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing. Biochemistry and biophysics reports, 31-6. https://doi.org/10.1016/j.bbrep.2015.07.001
Shimotai, Yoshitaka, et al. "The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing." Biochemistry and biophysics reports vol. 3 (2015): 1-6. doi: https://doi.org/10.1016/j.bbrep.2015.07.001
Shimotai Y, Goto T, Matsuzaki Y, Muraki Y, Sugawara K, Hongo S. The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing. Biochem Biophys Rep. 2015 Jul 08;3:1-6. doi: 10.1016/j.bbrep.2015.07.001. eCollection 2015 Sep. PMID: 29124162; PMCID: PMC5668659.
Copy Download .nbib Format: NLM
Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis.

Case reports in ophthalmology

Higashiyama T, Muraki S, Ohji M.
PMID: 28611651
Case Rep Ophthalmol. 2017 Mar 09;8(1):173-179. doi: 10.1159/000461575. eCollection 2017.

BACKGROUND: Laser therapy has been the gold standard treatment for retinopathy of prematurity (ROP), while intravitreal bevacizumab (IVB) is reported to be of significant benefit for zone I ROP. A problem with laser therapy is that it is difficult...

Cite
Higashiyama T, Muraki S, Ohji M. Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis. Case Rep Ophthalmol. 2017;8(1):173-179doi: 10.1159/000461575.
Higashiyama, T., Muraki, S., & Ohji, M. (2017). Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis. Case reports in ophthalmology, 8(1), 173-179. https://doi.org/10.1159/000461575
Higashiyama, Tomoaki, et al. "Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis." Case reports in ophthalmology vol. 8,1 (2017): 173-179. doi: https://doi.org/10.1159/000461575
Higashiyama T, Muraki S, Ohji M. Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis. Case Rep Ophthalmol. 2017 Mar 09;8(1):173-179. doi: 10.1159/000461575. eCollection 2017. PMID: 28611651; PMCID: PMC5465726.
Copy Download .nbib Format: NLM
Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza.

Journal of pharmaceutical health care and sciences

Murasaka T, Ikemura K, Enokiya T, Muraki Y, Ikemura M, Terada K, Iwamoto T, Okuda M.
PMID: 29152321
J Pharm Health Care Sci. 2017 Nov 08;3:26. doi: 10.1186/s40780-017-0094-7. eCollection 2017.

BACKGROUND: A dry powder inhaled formulation is used for the anti-influenza drug laninamivir octanoate hydrate (laninamivir). Although two successive inhalations (puffs) are recommended to minimize residual amounts of active ingredients, previous reports suggest that pediatric patients with low peak...

Cite
Murasaka T, Ikemura K, Enokiya T, et al. Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza. J Pharm Health Care Sci. 2017;3:26doi: 10.1186/s40780-017-0094-7.
Murasaka, T., Ikemura, K., Enokiya, T., Muraki, Y., Ikemura, M., Terada, K., Iwamoto, T., & Okuda, M. (2017). Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza. Journal of pharmaceutical health care and sciences, 326. https://doi.org/10.1186/s40780-017-0094-7
Murasaka, Toshiki, et al. "Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza." Journal of pharmaceutical health care and sciences vol. 3 (2017): 26. doi: https://doi.org/10.1186/s40780-017-0094-7
Murasaka T, Ikemura K, Enokiya T, Muraki Y, Ikemura M, Terada K, Iwamoto T, Okuda M. Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza. J Pharm Health Care Sci. 2017 Nov 08;3:26. doi: 10.1186/s40780-017-0094-7. eCollection 2017. PMID: 29152321; PMCID: PMC5678805.
Copy Download .nbib Format: NLM
In situ monitoring of thermal crystallization of ultrathin tris(8-hydroxyquinoline) aluminum films using surface-enhanced Raman scattering.

Applied spectroscopy

Muraki N.
PMID: 24405952
Appl Spectrosc. 2014;68(1):39-43. doi: 10.1366/13-07187.

Thermal crystallization of 3, 10, and 60 nm-thick tris(8-hydroxyquinoline)aluminum (Alq3) films is studied using surface-enhanced Raman scattering with a constant heating rate. An abrupt higher frequency shift of the quinoline-stretching mode is found to be an indication of a...

Cite
Muraki N. In situ monitoring of thermal crystallization of ultrathin tris(8-hydroxyquinoline) aluminum films using surface-enhanced Raman scattering. Appl Spectrosc. 2014;68(1):39-43doi: 10.1366/13-07187.
Muraki, N. (2014). In situ monitoring of thermal crystallization of ultrathin tris(8-hydroxyquinoline) aluminum films using surface-enhanced Raman scattering. Applied spectroscopy, 68(1), 39-43. https://doi.org/10.1366/13-07187
Muraki, Naoki. "In situ monitoring of thermal crystallization of ultrathin tris(8-hydroxyquinoline) aluminum films using surface-enhanced Raman scattering." Applied spectroscopy vol. 68,1 (2014): 39-43. doi: https://doi.org/10.1366/13-07187
Muraki N. In situ monitoring of thermal crystallization of ultrathin tris(8-hydroxyquinoline) aluminum films using surface-enhanced Raman scattering. Appl Spectrosc. 2014;68(1):39-43. doi: 10.1366/13-07187. PMID: 24405952.
Copy Download .nbib Format: NLM
Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review.

Case reports in pathology

Kuroda S, Suzuki S, Kurita A, Muraki M, Aoshima Y, Tanioka F, Sugimura H.
PMID: 25685583
Case Rep Pathol. 2015;2015:572951. doi: 10.1155/2015/572951. Epub 2015 Jan 19.

Background. Nuclear protein in testis (NUT) midline carcinoma (NMC) is a very rare and aggressive malignancy. In more than two-thirds of these NMC cases, a fusion between NUT and BRD4 or BRD3 has been documented; other variants are rare....

Cite
Kuroda S, Suzuki S, Kurita A, et al. Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review. Case Rep Pathol. 2015;2015:572951doi: 10.1155/2015/572951.
Kuroda, S., Suzuki, S., Kurita, A., Muraki, M., Aoshima, Y., Tanioka, F., & Sugimura, H. (2015). Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review. Case reports in pathology, 2015572951. https://doi.org/10.1155/2015/572951
Kuroda, Shiho, et al. "Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review." Case reports in pathology vol. 2015 (2015): 572951. doi: https://doi.org/10.1155/2015/572951
Kuroda S, Suzuki S, Kurita A, Muraki M, Aoshima Y, Tanioka F, Sugimura H. Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review. Case Rep Pathol. 2015;2015:572951. doi: 10.1155/2015/572951. Epub 2015 Jan 19. PMID: 25685583; PMCID: PMC4320876.
Copy Download .nbib Format: NLM
Exoplanet detection. A terrestrial planet in a ~1-AU orbit around one member of a ~15-AU binary.

Science (New York, N.Y.)

Gould A, Udalski A, Shin IG, Porritt I, Skowron J, Han C, Yee JC, Kozłowski S, Choi JY, Poleski R, Wyrzykowski Ł, Ulaczyk K, Pietrukowicz P, Mróz P, Szymański MK, Kubiak M, Soszyński I, Pietrzyński G, Gaudi BS, Christie GW, Drummond J, McCormick J, Natusch T, Ngan H, Tan TG, Albrow M, DePoy DL, Hwang KH, Jung YK, Lee CU, Park H, Pogge RW, Abe F, Bennett DP, Bond IA, Botzler CS, Freeman M, Fukui A, Fukunaga D, Itow Y, Koshimoto N, Larsen P, Ling CH, Masuda K, Matsubara Y, Muraki Y, Namba S, Ohnishi K, Philpott L, Rattenbury NJ, Saito T, Sullivan DJ, Sumi T, Suzuki D, Tristram PJ, Tsurumi N, Wada K, Yamai N, Yock PC, Yonehara A, Shvartzvald Y, Maoz D, Kaspi S, Friedmann M.
PMID: 24994642
Science. 2014 Jul 04;345(6192):46-9. doi: 10.1126/science.1251527.

Using gravitational microlensing, we detected a cold terrestrial planet orbiting one member of a binary star system. The planet has low mass (twice Earth's) and lies projected at ~0.8 astronomical units (AU) from its host star, about the distance...

Cite
Gould A, Udalski A, Shin IG, et al. Exoplanet detection. A terrestrial planet in a ~1-AU orbit around one member of a ~15-AU binary. Science. 2014;345(6192):46-9doi: 10.1126/science.1251527.
Gould, A., Udalski, A., Shin, I. G., Porritt, I., Skowron, J., Han, C., Yee, J. C., Kozłowski, S., Choi, J. Y., Poleski, R., Wyrzykowski, �. �., Ulaczyk, K., Pietrukowicz, P., Mróz, P., Szymański, M. K., Kubiak, M., Soszyński, I., Pietrzyński, G., Gaudi, B. S., Christie, G. W., Drummond, J., McCormick, J., Natusch, T., Ngan, H., Tan, T. G., Albrow, M., DePoy, D. L., Hwang, K. H., Jung, Y. K., Lee, C. U., Park, H., Pogge, R. W., Abe, F., Bennett, D. P., Bond, I. A., Botzler, C. S., Freeman, M., Fukui, A., Fukunaga, D., Itow, Y., Koshimoto, N., Larsen, P., Ling, C. H., Masuda, K., Matsubara, Y., Muraki, Y., Namba, S., Ohnishi, K., Philpott, L., Rattenbury, N. J., Saito, T., Sullivan, D. J., Sumi, T., Suzuki, D., Tristram, P. J., Tsurumi, N., Wada, K., Yamai, N., Yock, P. C., Yonehara, A., Shvartzvald, Y., Maoz, D., Kaspi, S., & Friedmann, M. (2014). Exoplanet detection. A terrestrial planet in a ~1-AU orbit around one member of a ~15-AU binary. Science (New York, N.Y.), 345(6192), 46-9. https://doi.org/10.1126/science.1251527
Gould, A, et al. "Exoplanet detection. A terrestrial planet in a ~1-AU orbit around one member of a ~15-AU binary." Science (New York, N.Y.) vol. 345,6192 (2014): 46-9. doi: https://doi.org/10.1126/science.1251527
Gould A, Udalski A, Shin IG, Porritt I, Skowron J, Han C, Yee JC, Kozłowski S, Choi JY, Poleski R, Wyrzykowski Ł, Ulaczyk K, Pietrukowicz P, Mróz P, Szymański MK, Kubiak M, Soszyński I, Pietrzyński G, Gaudi BS, Christie GW, Drummond J, McCormick J, Natusch T, Ngan H, Tan TG, Albrow M, DePoy DL, Hwang KH, Jung YK, Lee CU, Park H, Pogge RW, Abe F, Bennett DP, Bond IA, Botzler CS, Freeman M, Fukui A, Fukunaga D, Itow Y, Koshimoto N, Larsen P, Ling CH, Masuda K, Matsubara Y, Muraki Y, Namba S, Ohnishi K, Philpott L, Rattenbury NJ, Saito T, Sullivan DJ, Sumi T, Suzuki D, Tristram PJ, Tsurumi N, Wada K, Yamai N, Yock PC, Yonehara A, Shvartzvald Y, Maoz D, Kaspi S, Friedmann M. Exoplanet detection. A terrestrial planet in a ~1-AU orbit around one member of a ~15-AU binary. Science. 2014 Jul 04;345(6192):46-9. doi: 10.1126/science.1251527. PMID: 24994642.
Copy Download .nbib Format: NLM
Detection and Control of Spin-Orbit Interactions in a GaAs Hole Quantum Point Contact.

Physical review letters

Srinivasan A, Miserev DS, Hudson KL, Klochan O, Muraki K, Hirayama Y, Reuter D, Wieck AD, Sushkov OP, Hamilton AR.
PMID: 28430471
Phys Rev Lett. 2017 Apr 07;118(14):146801. doi: 10.1103/PhysRevLett.118.146801. Epub 2017 Apr 05.

We investigate the relationship between the Zeeman interaction and the inversion-asymmetry-induced spin-orbit interactions (Rashba and Dresselhaus SOIs) in GaAs hole quantum point contacts. The presence of a strong SOI results in the crossing and anticrossing of adjacent spin-split hole...

Cite
Srinivasan A, Miserev DS, Hudson KL, et al. Detection and Control of Spin-Orbit Interactions in a GaAs Hole Quantum Point Contact. Phys Rev Lett. 2017;118(14):146801doi: 10.1103/PhysRevLett.118.146801.
Srinivasan, A., Miserev, D. S., Hudson, K. L., Klochan, O., Muraki, K., Hirayama, Y., Reuter, D., Wieck, A. D., Sushkov, O. P., & Hamilton, A. R. (2017). Detection and Control of Spin-Orbit Interactions in a GaAs Hole Quantum Point Contact. Physical review letters, 118(14), 146801. https://doi.org/10.1103/PhysRevLett.118.146801
Srinivasan, A, et al. "Detection and Control of Spin-Orbit Interactions in a GaAs Hole Quantum Point Contact." Physical review letters vol. 118,14 (2017): 146801. doi: https://doi.org/10.1103/PhysRevLett.118.146801
Srinivasan A, Miserev DS, Hudson KL, Klochan O, Muraki K, Hirayama Y, Reuter D, Wieck AD, Sushkov OP, Hamilton AR. Detection and Control of Spin-Orbit Interactions in a GaAs Hole Quantum Point Contact. Phys Rev Lett. 2017 Apr 07;118(14):146801. doi: 10.1103/PhysRevLett.118.146801. Epub 2017 Apr 05. PMID: 28430471.
Copy Download .nbib Format: NLM
Negative and positive cross-correlations of current noises in quantum Hall edge channels at bulk filling factor [Formula: see text].

Journal of physics. Condensed matter : an Institute of Physics journal

Ota T, Hashisaka M, Muraki K, Fujisawa T.
PMID: 28401878
J Phys Condens Matter. 2017 Jun 07;29(22):225302. doi: 10.1088/1361-648X/aa6cc0. Epub 2017 Apr 12.

Cross-correlation noise in electrical currents generated from a series connection of two quantum point contacts (QPCs), the injector and the detector, is described for investigating energy relaxation in quantum Hall edge channels at bulk filling factor [Formula: see text]....

Cite
Ota T, Hashisaka M, Muraki K, et al. Negative and positive cross-correlations of current noises in quantum Hall edge channels at bulk filling factor [Formula: see text]. J Phys Condens Matter. 2017;29(22):225302doi: 10.1088/1361-648X/aa6cc0.
Ota, T., Hashisaka, M., Muraki, K., & Fujisawa, T. (2017). Negative and positive cross-correlations of current noises in quantum Hall edge channels at bulk filling factor [Formula: see text]. Journal of physics. Condensed matter : an Institute of Physics journal, 29(22), 225302. https://doi.org/10.1088/1361-648X/aa6cc0
Ota, T, et al. "Negative and positive cross-correlations of current noises in quantum Hall edge channels at bulk filling factor [Formula: see text]." Journal of physics. Condensed matter : an Institute of Physics journal vol. 29,22 (2017): 225302. doi: https://doi.org/10.1088/1361-648X/aa6cc0
Ota T, Hashisaka M, Muraki K, Fujisawa T. Negative and positive cross-correlations of current noises in quantum Hall edge channels at bulk filling factor [Formula: see text]. J Phys Condens Matter. 2017 Jun 07;29(22):225302. doi: 10.1088/1361-648X/aa6cc0. Epub 2017 Apr 12. PMID: 28401878.
Copy Download .nbib Format: NLM
Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor.

PloS one

Yoshimura Y, Shiino A, Muraki K, Fukami T, Yamada S, Satow T, Fukuda M, Saiki M, Hojo M, Miyamoto S, Onishi N, Saya H, Inubushi T, Nozaki K, Tanigaki K.
PMID: 26882340
PLoS One. 2016 Feb 16;11(2):e0149826. doi: 10.1371/journal.pone.0149826. eCollection 2016.

No abstract available.

Cite
Yoshimura Y, Shiino A, Muraki K, et al. Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor. PLoS One. 2016;11(2):e0149826doi: 10.1371/journal.pone.0149826.
Yoshimura, Y., Shiino, A., Muraki, K., Fukami, T., Yamada, S., Satow, T., Fukuda, M., Saiki, M., Hojo, M., Miyamoto, S., Onishi, N., Saya, H., Inubushi, T., Nozaki, K., & Tanigaki, K. (2016). Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor. PloS one, 11(2), e0149826. https://doi.org/10.1371/journal.pone.0149826
Yoshimura, Yayoi, et al. "Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor." PloS one vol. 11,2 (2016): e0149826. doi: https://doi.org/10.1371/journal.pone.0149826
Yoshimura Y, Shiino A, Muraki K, Fukami T, Yamada S, Satow T, Fukuda M, Saiki M, Hojo M, Miyamoto S, Onishi N, Saya H, Inubushi T, Nozaki K, Tanigaki K. Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor. PLoS One. 2016 Feb 16;11(2):e0149826. doi: 10.1371/journal.pone.0149826. eCollection 2016. PMID: 26882340; PMCID: PMC4755589.
Copy Download .nbib Format: NLM
Preparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugation.

SpringerPlus

Muraki M.
PMID: 27398274
Springerplus. 2016 Jul 07;5(1):997. doi: 10.1186/s40064-016-2673-8. eCollection 2016.

BACKGROUND: Human Fas ligand extracellular domain has been investigated as an important target protein in the field of medical biotechnology. In a recent study, the author developed an effective method to produce biologically active human Fas ligand extracellular domain...

Cite
Muraki M. Preparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugation. Springerplus. 2016;5(1):997doi: 10.1186/s40064-016-2673-8.
Muraki, M. (2016). Preparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugation. SpringerPlus, 5(1), 997. https://doi.org/10.1186/s40064-016-2673-8
Muraki, Michiro. "Preparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugation." SpringerPlus vol. 5,1 (2016): 997. doi: https://doi.org/10.1186/s40064-016-2673-8
Muraki M. Preparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugation. Springerplus. 2016 Jul 07;5(1):997. doi: 10.1186/s40064-016-2673-8. eCollection 2016. PMID: 27398274; PMCID: PMC4936993.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 291 entries